References
- Gabriel C, Gabriel S, Corthout E. (1996). The dielectric properties of biological tissues: I. Literature survey. Phys Med Biol 41:2231–49.
- Gabriel S, Lau RW, Gabriel C. (1996). The dielectric properties of biological tissues: III. Parametric models for the dielectric spectrum of tissues. Phys Med Biol 41:2271–93.3.
- Lubner MG, Brace CL, Hinshaw JL, Lee FT. (2010). Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 21(8 Suppl):S192–S203.
- Ward RC, Healey TT, Dupuy DE. (2013). Microwave ablation devices for interventional oncology. Expert Rev Med Devices 10:225–38.
- Chu KF, Dupuy DE. (2014). Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 14:199–208.
- Mizukoshi E, Yamashita T, Arai K, et al. (2013). Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma. Hepatology 57:1448–57.
- Keisari Y, Hochman I, Confino H, et al. (2014). Activation of local and systemic anti-tumor immune responses by ablation of solid tumors with intratumoral electrochemical or alpha radiation treatments. Cancer Immunol Immunother 63:1–9.
- Ahmed M, Brace CL, Lee FT, Goldberg SN. (2011). Principles of and advances in percutaneous ablation. Radiology 258:351–69.
- Spolverato G, Vitale A, Ejaz A, et al. (2015). The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. World J Surg 39:1474–84.
- Welch BT, Brinjikji W, Schmit GD, et al. (2015). A national analysis of the complications, cost, and mortality of percutaneous lung ablation. J Vasc Interv Radiol 26:787–91.
- Wright AS, Sampson LA, Warner TF, et al. (2005). Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 236:132–9.
- Lu DS, Yu NC, Raman SS, et al. (2005). Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 234:954–60.
- Lanuti M, Sharma A, Willers H, et al. (2012). Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence. Ann Thorac Surg 93:921–7.
- Velez E, Goldberg SN, Kumar G, et al. (2016). Hepatic thermal ablation: effect of device and heating parameters on local tissue reactions and distant tumor growth. Radiology 281:782–92.
- Lu DS, Raman SS, Vodopich DJ, et al. (2002). Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect. AJR Am J Roentgenol 178:47–51.
- Lehmann KS, Poch FG, Rieder C, et al. (2016). Minimal vascular flows cause strong heat sink effects in hepatic radiofrequency ablation ex vivo. J Hepatobiliary Pancreat Sci 23:508–16.
- Deshazer G, Merck D, Hagmann M, et al. (2016). Physical modeling of microwave ablation zone clinical margin variance. Med Phys 43:1764.
- Park WKC, Maxwell AWP, Frank VE, et al. (2017). evaluation of a novel thermal accelerant for augmentation of microwave energy during image-guided tumor ablation. Theranostics 7:1026.
- Hands-on Science (H-Sci) Project: Chemical Safety Database. Physical and Theoretical Chemistry Laboratory. Oxford University.
- Chemical and Other Safety Information. The Physical and Theoretical Chemistry Laboratory, Oxford University.
- Wiens M, Gordon W, Baulcomb D, et al. (2009). Cesium chloride-induced torsades de pointes. Can J Cardiol 25:e329–31.
- Sessions D, Heard K, Kosnett M. (2013). Fatal cesium chloride toxicity after alternative cancer treatment. J Altern Complement Med 19:973–5.
- Garrean S, Hering J, Saied A, et al. (2009). Ultrasound monitoring of a novel microwave ablation (MWA) device in porcine liver: lessons learned and phenomena observed on ablative effects near major intrahepatic vessels. J Gastrointest Surg 13:334–40.
- Gravante G, Ong SL, Metcalfe MS, et al. (2008). Hepatic microwave ablation: a review of the histological changes following thermal damage. Liver Int 28:911–21.
- Goldberg SN, Hahn PF, Halpern EF, et al. (1998). Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 209:761–7.
- Patterson EJ, Scudamore CH, Owen DA, et al. (1998). Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 227:559–65.
- Goldberg SN, Hahn PF, Tanabe KK, et al. (1998). Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 9(1 Pt 1):101–11.
- Livraghi T, Goldberg SN, Monti F, et al. (1997). Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 202:205–10.
- Ahmed M, Lobo SM, Weinstein J, et al. (2002). Improved coagulation with saline solution pretreatment during radiofrequency tumor ablation in a canine model. J Vasc Interv Radiol 13:717–24.
- Kettenbach J, Köstler W, Rücklinger E, et al. (2003). Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. AJR Am J Roentgenol 180:1537–45.
- Giorgio A, Tarantino L, de Stefano G, et al. (2003). Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. AJR Am J Roentgenol 181:479–84.
- Gillams AR, Lees WR. (2005). CT mapping of the distribution of saline during radiofrequency ablation with perfusion electrodes. Cardiovasc Intervent Radiol 28:476–80.